BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36878191)

  • 21. Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders.
    Sakinyte K; Holmberg C
    BMC Psychiatry; 2023 Mar; 23(1):207. PubMed ID: 36978160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spanish validation of the adult Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS): relevance of clinical subtypes.
    Richarte V; Corrales M; Pozuelo M; Serra-Pla J; Ibáñez P; Calvo E; Corominas M; Bosch R; Casas M; Ramos-Quiroga JA
    Rev Psiquiatr Salud Ment; 2017; 10(4):185-191. PubMed ID: 28844652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
    Rekhi G; Alphs L; Ang MS; Lee J
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.
    Kao YC; Liu YP
    BMC Psychiatry; 2010 Aug; 10():63. PubMed ID: 20718964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The WERCAP Screen and the WERC Stress Screen: psychometrics of self-rated instruments for assessing bipolar and psychotic disorder risk and perceived stress burden.
    Mamah D; Owoso A; Sheffield JM; Bayer C
    Compr Psychiatry; 2014 Oct; 55(7):1757-71. PubMed ID: 25128205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
    Martínez-Cao C; García-Álvarez L; Bobes-Bascarán T; de la Fuente-Tomás L; Fernández-Egea E; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz-Martínez PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):22-28. PubMed ID: 35256069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years.
    Kotzalidis GD; Solfanelli A; Piacentino D; Savoja V; Fiori Nastro P; Curto M; Lindau JF; Masillo A; Brandizzi M; Fagioli F; Raballo A; Gebhardt E; Preti A; D'Alema M; Fucci MR; Miletto R; Andropoli D; Leccisi D; Girardi P; Loewy RL; Schultze-Lutter F
    Schizophr Res; 2017 Nov; 189():50-56. PubMed ID: 28254200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS).
    Goetz RR; Corcoran C; Yale S; Stanford AD; Kimhy D; Amador X; Malaspina D
    Schizophr Res; 2007 Jul; 93(1-3):169-77. PubMed ID: 17433629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the link between cognitive deficit, self-esteem, alexithymia, and depressive symptom of schizophrenia.
    He C; Zhang X; Xia Q; Gao H; Yan J; Chen X; Yuan H; Zhang Y; Xie W; Zhu C
    Brain Behav; 2022 Jul; 12(7):e2648. PubMed ID: 35676241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
    Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics of theory of mind impairment and its relationship with clinical symptoms and neurocognition in patients with schizophrenia.
    Wu Y; Song S; Shen Y
    BMC Psychiatry; 2023 Oct; 23(1):711. PubMed ID: 37784072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
    Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
    BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.
    Ludwig KA; Pinkham AE; Harvey PD; Kelsven S; Penn DL
    Schizophr Res; 2017 Dec; 190():136-143. PubMed ID: 28302395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spanish validation of the self-evaluation of negative symptoms scale SNS in an adolescent population.
    Rodríguez-Testal JF; Perona-Garcelán S; Dollfus S; Valdés-Díaz M; García-Martínez J; Ruíz-Veguilla M; Senín-Calderón C
    BMC Psychiatry; 2019 Oct; 19(1):327. PubMed ID: 31664965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Important Role of Motivation and Pleasure Deficits on Social Functioning in Patients With Schizophrenia: A Network Analysis.
    Hu HX; Lau WYS; Ma EPY; Hung KSY; Chen SY; Cheng KS; Cheung EFC; Lui SSY; Chan RCK
    Schizophr Bull; 2022 Jun; 48(4):860-870. PubMed ID: 35524755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Performance of Exposome Score for Schizophrenia in the General Population.
    Pries LK; Erzin G; van Os J; Ten Have M; de Graaf R; van Dorsselaer S; Bak M; Rutten BPF; Guloksuz S
    Schizophr Bull; 2021 Mar; 47(2):277-283. PubMed ID: 33215211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility.
    Ritsner MS; Mar M; Arbitman M; Grinshpoon A
    Psychiatry Res; 2013 Jun; 208(1):1-8. PubMed ID: 23582209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.